Plasma Kallikrein Inhibitor [EPC] - N0000192750

Pharmacologic Class Information

Pharmacologic Code N0000192750
Pharmacologic Name Plasma Kallikrein Inhibitor
Pharmacologic Uses
  • plasma kallikrein inhibitor
Pharmacologic Concept Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions:
  • A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication.
  • A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with Plasma Kallikrein Inhibitor

The table contains 6 products whose active ingredient are classified under the same pharmacologic class Plasma Kallikrein Inhibitor [EPC].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
72769-101Orladeyo Non-Proprietary Name: Berotralstat HydrochlorideCapsuleOralBiocryst Pharmaceuticals Inc.ACTIVE
47783-644Takhzyro Non-Proprietary Name: Lanadelumab-flyoInjection, SolutionSubcutaneousTakeda Pharmaceuticals America, Inc.ACTIVE
47783-646Takhzyro Non-Proprietary Name: Lanadelumab-flyoSolutionSubcutaneousTakeda Pharmaceuticals America, Inc.ACTIVE
72769-102Orladeyo Non-Proprietary Name: Berotralstat HydrochlorideCapsuleOralBiocryst Pharmaceuticals Inc.ACTIVE
47783-101Kalbitor Non-Proprietary Name: EcallantideInjection, SolutionSubcutaneousTakeda Pharmaceuticals America, Inc.ACTIVE
47783-645Takhzyro Non-Proprietary Name: Lanadelumab-flyoSolutionSubcutaneousTakeda Pharmaceuticals America, Inc.ACTIVE